Literature DB >> 8630401

Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells.

C Caux1, B Vanbervliet, C Massacrier, I Durand, J Banchereau.   

Abstract

We have previously shown that tumor necrosis factor (TNF)alpha strongly potentiates the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin (IL)-3-dependent proliferation of CD34+ hematopoietic progenitor cells (HPC) through the recruitment of early progenitors with high proliferative potential. Furthermore, the combination of GM-CSF and TNFalpha allows the generation of large numbers of dendritic/Langerhans cells (D-Lc). Herein, we analyzed whether IL-3, when combined to TNFalpha would, as does GM-CSF, allow the generation of CD1a+ D-Lc. Accordingly, cultures of cord blood CD34+ HPC with IL-3 + TNFalpha yielded 20% to 60% CD14+ cells and 11% to 17% CD1a+ cells, while IL-3 alone did not generate significant numbers of CD1a+ cells. Although the percentage of CD1a+ cells detected in IL3 + TNFalpha was lower than that observed in GM-CSF + TNFalpha (42% to 78%), the strong growth induced by IL-3 + TNFalpha generated as many CD1a+ cells as did GM-CSF + TNFalpha. The CD14+ and CD1a+ cells generated with IL-3 + TNFalpha are similar to CD14+ and CD1a+ cells generated in GM-CSF alone and GM-CSF + TNFalpha, respectively. CD1a+ cells differed from CD14+ cells by (1) dendritic morphology, (2) higher expression of CD1a, CD1c, CD4, CD40, adhesion molecules (CD11c, CD54, CD58), major histocompatibility complex (MHC) class II molecules and CD28 ligands (CD80 and CD86), (3) lack of Fc receptor FcgammaRI (CD64) and complement receptor CR1 (CD35) expression, and (4) stronger induction of allogeneic T-cell proliferation. Thus, in combination with TNFalpha, IL-3 is as potent as GM-CSF for the generation of CD1a+ D-Lc from cord blood CD34+ HPC. The dendritic cell inducing ability of IL-3 may explain why mice with inactivated GM-CSF gene display dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630401

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants.

Authors:  A T Larregina; A E Morelli; E Kolkowski; N Sanjuan; M E Barboza; L Fainboim
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Interleukin-3 receptors in Hodgkin's disease.

Authors:  Herbert Bosshart
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 3.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

4.  The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance.

Authors:  David L Stachura; Ondrej Svoboda; Clyde A Campbell; Raquel Espín-Palazón; Ryan P Lau; Leonard I Zon; Petr Bartunek; David Traver
Journal:  Blood       Date:  2013-10-15       Impact factor: 22.113

5.  Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin.

Authors:  J Olweus; A BitMansour; R Warnke; P A Thompson; J Carballido; L J Picker; F Lund-Johansen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.

Authors:  L Matera; A Galetto; M Geuna; K Vekemans; E Ricotti; M Contarini; F Moro; G Basso
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

7.  Role of macrophage colony-stimulating factor in the differentiation and expansion of monocytes and dendritic cells from CD34+ progenitor cells.

Authors:  A W Kamps; D Hendriks; J W Smit; E Vellenga
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

8.  Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha.

Authors:  Yong-Mei Guo; Makoto Hirokawa; Naoto Takahashi; Masumi Fujishima; Naohito Fujishima; Atsushi Komatsuda; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Miwa Hebiguchi; Weiguo Xiao; Kenichi Sawada
Journal:  Int J Hematol       Date:  2009-12-12       Impact factor: 2.490

9.  Leukemic transformation of Langerhans cell sarcoma.

Authors:  Kousuke Sumida; Yuya Yoshidomi; Hiroko Koga; Nobuo Kuwahara; Eijo Matsuishi; Kennosuke Karube; Koichi Oshima; Hisashi Gondo
Journal:  Int J Hematol       Date:  2008-03-22       Impact factor: 2.490

10.  IL-33 promotes DC development in BM culture by triggering GM-CSF production.

Authors:  Nobuyasu Mayuzumi; Hironori Matsushima; Akira Takashima
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.